ANEBULO PHARMACEUTICALS INC (ANEB) Stock Analyst Ratings
USA - NASDAQ:ANEB - US0345691036 - Common Stock
2.31 USD
-0.09 (-3.75%)
2.31 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to ANEB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 253.25% above the current price.
ANEB was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ANEB.
In the previous month the buy percentage consensus was at a similar level.
ANEB was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-23 | Maxim Group | Downgrade | Buy -> Hold |
| 2025-05-15 | Maxim Group | Maintains | Buy -> Buy |
| 2024-11-19 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-10-01 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-10-03 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-09-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-21 | Maxim Group | Initiate | Buy |
| 2023-09-18 | HC Wainwright & Co. | Initiate | Buy |
| 2023-05-18 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-02-14 | Benchmark | Maintains | Speculative Buy |
| 2022-07-27 | Ladenburg Thalmann | Initiate | Buy |
| 2021-05-25 | Benchmark | Initiate | Buy |